#Ozempic #USpharma
Novo Nordisk, the maker of Ozempic, criticized President Biden after he accused them of overcharging US consumers. Biden and Senator Sanders condemned high drug prices. Novo Nordisk defended itself, highlighting price reductions and complexities in healthcare systems. read more
There are no other USpharma articles to read at this time.
Check out some of these other topics...